Barclays Raises Celestica Inc. (CLS) Price Target to $391, Reiterates Overweight

We recently published an article titled 11 Best Canadian Growth Stocks to Buy According to Hedge Funds. On January 30, Barclays raised its price target on Celestica Inc. (NYSE:CLS) to $391 from $359 while reiterating an Overweight rating, following the company’s upward revision to its fiscal 2026 outlook by approximately $1 billion. The analyst characterized the updated guidance as conservative, suggesting there is room for further upward revisions as the year progresses. Barclays’ constructive stance ref ...